iRhythm Technologies' shares dropped more than 30% after reporting Q3 revenue below Wall Street expectations and flat sales of its Zio AT device. The company also delayed the FDA submission of its next-generation Zio MCT device to 2027, citing integration challenges after acquiring VitalConnect. An investigation into potential securities law violations has been announced for investors who suffered losses, offering a free review of eligibility for recovery. This development raises concerns about the company's future product pipeline and financial performance.
iRhythm Technologies shares are the subject, with Pluang market data providing context. For readers following the health sector, here is Pluang's market snapshot as of Nov 07, 2026 04:02 WIB: Out of 150 priced health-sector US stocks, 77 rose and 72 fell. Notable movers include IMVT at USD 31.09 with a 9.51% increase and a typical hold time of 16 days, ILMN at USD 205.01 down 9.50% with 100% sell order activity, and ELAN at USD 25.66 up 8.41% with balanced buy/sell orders.
Arcutis Biotherapeutics awarded 58,500 restricted stock units and options for 17,000 shares to six new employees as an inducement to join the company. The grants, approved under Nasdaq Listing Rule 5635(c)(4), vest over four years with specific sched...
The music duo for KING + COUNTRY released the Drummer Boy (Original Motion Picture Soundtrack) to coincide with the nationwide launch of their Christmas film DRUMMER BOY. The soundtrack features original songs by Joel and Luke Smallbone, reimagined C...
HMG Strategy is holding its first Tennessee C-Level Technology Leadership Summit on November 13 at W Nashville, bringing together CIOs, CISOs, CTOs, and senior tech executives from across Tennessee and the Mid-South. The summit will focus on AI, cybe...
Ipsen has disclosed its monthly update on the total number of shares and voting rights as of October 31, 2026. The company reported 83,814,526 shares composing the share capital, with a gross total of 132,059,377 voting rights and a net total of 130,...
At its 2026 International User Summit, Chery unveiled its Globalization 3.0 strategy, moving beyond export-driven growth to emphasize deep localization, sustainable development, and community engagement. The company is expanding local R&D, manufactur...
